These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 39013532)
1. Histidine as a versatile excipient in the protein-based biopharmaceutical formulations. Lv JY; Ingle RG; Wu H; Liu C; Fang WJ Int J Pharm; 2024 Sep; 662():124472. PubMed ID: 39013532 [TBL] [Abstract][Full Text] [Related]
2. Polysorbates versus Hydroxypropyl Beta-Cyclodextrin (HPβCD): Comparative Study on Excipient Stability and Stabilization Benefits on Monoclonal Antibodies. Zhang H; Hong S; Tan SSK; Peng T; Goh LYH; Lam KH; Chow KT; Gokhale R Molecules; 2022 Oct; 27(19):. PubMed ID: 36235038 [TBL] [Abstract][Full Text] [Related]
3. Degradation of polysorbates 20 and 80 catalysed by histidine chloride buffer. Brovč EV; Mravljak J; Šink R; Pajk S Eur J Pharm Biopharm; 2020 Sep; 154():236-245. PubMed ID: 32693155 [TBL] [Abstract][Full Text] [Related]
4. Investigation of excipients impact on polysorbate 80 degradation in biopharmaceutical formulation buffers. Bai L; Zhang Y; Zhang C; Lu Y; Li Z; Huang G; Meng B J Pharm Biomed Anal; 2023 Sep; 233():115496. PubMed ID: 37285658 [TBL] [Abstract][Full Text] [Related]
5. Protein-protein interactions and water activity coefficients can be used to aid a first excipient choice in protein formulations. Schleinitz M; Sadowski G; Brandenbusch C Int J Pharm; 2019 Oct; 569():118608. PubMed ID: 31415881 [TBL] [Abstract][Full Text] [Related]
6. Arginine as an Excipient for Protein Freeze-Drying: A Mini Review. Stärtzel P J Pharm Sci; 2018 Apr; 107(4):960-967. PubMed ID: 29183741 [TBL] [Abstract][Full Text] [Related]
7. Theoretical analysis of excipient concentrations during the final ultrafiltration/diafiltration step of therapeutic antibody. Miao F; Velayudhan A; DiBella E; Shervin J; Felo M; Teeters M; Alred P Biotechnol Prog; 2009; 25(4):964-72. PubMed ID: 19569193 [TBL] [Abstract][Full Text] [Related]
8. Effects of arginine in therapeutic protein formulations: a decade review and perspectives. Ren S Antib Ther; 2023 Oct; 6(4):265-276. PubMed ID: 38075239 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous quantification of polysorbate 20 and poloxamer 188 in biopharmaceutical formulations using evaporative light scattering detection. Paschen CA; Klemm D; Graf T; Kopf R; Pinto C; Müller C; Bell CH; Pfaff J J Pharm Biomed Anal; 2021 Jan; 192():113640. PubMed ID: 33002754 [TBL] [Abstract][Full Text] [Related]
10. Effect of protein and solution properties on the Donnan effect during the ultrafiltration of proteins. Bolton GR; Boesch AW; Basha J; Lacasse DP; Kelley BD; Acharya H Biotechnol Prog; 2011; 27(1):140-52. PubMed ID: 21312362 [TBL] [Abstract][Full Text] [Related]
11. Investigation on the Combined Effect of Hydroxypropyl Beta-Cyclodextrin (HPβCD) and Polysorbate in Monoclonal Antibody Formulation. Huang J; Hong S; Goh LYH; Zhang H; Peng T; Chow KT; Gokhale R; Tuliani V Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675488 [TBL] [Abstract][Full Text] [Related]
12. Analysis methods of polysorbate 20: A new method to assess the stability of polysorbate 20 and established methods that may overlook degraded polysorbate 20. Khossravi M; Kao YH; Mrsny RJ; Sweeney TD Pharm Res; 2002 May; 19(5):634-9. PubMed ID: 12069166 [TBL] [Abstract][Full Text] [Related]
13. Considerations for the Use of Polysorbates in Biopharmaceuticals. Jones MT; Mahler HC; Yadav S; Bindra D; Corvari V; Fesinmeyer RM; Gupta K; Harmon AM; Hinds KD; Koulov A; Liu W; Maloney K; Wang J; Yeh PY; Singh SK Pharm Res; 2018 May; 35(8):148. PubMed ID: 29797101 [TBL] [Abstract][Full Text] [Related]
14. Trends on Analytical Characterization of Polysorbates and Their Degradation Products in Biopharmaceutical Formulations. Martos A; Koch W; Jiskoot W; Wuchner K; Winter G; Friess W; Hawe A J Pharm Sci; 2017 Jul; 106(7):1722-1735. PubMed ID: 28302541 [TBL] [Abstract][Full Text] [Related]
15. Acidic and alkaline hydrolysis of polysorbates under aqueous conditions: Towards understanding polysorbate degradation in biopharmaceutical formulations. Dwivedi M; Buske J; Haemmerling F; Blech M; Garidel P Eur J Pharm Sci; 2020 Mar; 144():105211. PubMed ID: 31931121 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of a selective marker-based quantification of polysorbate 20 in biopharmaceutical formulations using UPLC QDa detection. Evers DH; Schultz-Fademrecht T; Garidel P; Buske J J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1157():122287. PubMed ID: 33069954 [TBL] [Abstract][Full Text] [Related]
17. Control of Globular Protein Thermal Stability in Aqueous Formulations by the Positively Charged Amino Acid Excipients. Platts L; Darby SJ; Falconer RJ J Pharm Sci; 2016 Dec; 105(12):3532-3536. PubMed ID: 27776770 [TBL] [Abstract][Full Text] [Related]